Lv11
80 积分 2024-01-12 加入
Targeting the IL-17A Cytokine Interface: Structural Insights and Small-Molecule Modulators
5天前
已完结
Route Design, Process Development, and Manufacture of XL495: An Atropisomeric PKMYT1 Inhibitor
17天前
已完结
Elinzanetant: Defining the Role of Dual Neurokinin-1 and Neurokinin-3 Receptor Antagonism for Management of Vasomotor Symptoms in Menopause
1个月前
已完结
Optimization of Novel Antagonists to the Neurokinin-3 Receptor for the Treatment of Sex-Hormone Disorders (Part II)
1个月前
已完结
Discovery and Optimization of Novel Antagonists to the Human Neurokinin-3 Receptor for the Treatment of Sex-Hormone Disorders (Part I)
1个月前
已完结
Discovery of Potent, Orally Bioavailable, Tricyclic NLRP3 Inhibitors
2个月前
已完结
Design, synthesis, and biological evaluation of 3-phenyl substituted pyridine derivatives as potential dual inhibitors of XOR and URAT1
2个月前
已完结
(E)-2-(4-bromophenyl)-1-(2, 4-dihydroxyphenyl)ethanone oxime is a potential therapeutic agent for treatment of hyperuricemia through its dual inhibitory effects on XOD and URAT1
2个月前
已完结
Acute kidney injury observed during phase 1 clinical trials of a novel xanthine oxidase/URAT1 dual inhibitor PF-06743649
2个月前
已完结
皖公网安备34019202002308
